NMPA secured for China Hearing Aid Launch
Filed with ASX · · 3 pages · English
▸ NMPA certification secured, confirming full regulatory approval for launch in China. ▸ Product positioned within a market‑leading hearing aid brand sold through China’s top e-commerce channels. ▸ Supports large-scale commercial rollout and visibility across dominant online healthcare platforms. ▸ Strengthens Audeara’s strategy to drive repeatable, high‑margin licensing revenue through global par
Story so far
Earlier from Audeara
- $1.22m R&D Tax Incentive received
- Q1 FY26 Quarterly Activities Report & Appendix 4C
- Maiden purchase order secured for China hearing aid market
- Appendix 4E and Annual Report 2025
- Q1 FY26 revenue up 46% on last quarter to over $1m
Later from Audeara
- December Trading Update
- Q2 FY26 Quarterly Activities Report & Appendix 4C
- Appendix 4D & Half-Year Financial Report to 31 December 2025
- Auracast platform expansion underway with Clinico Inc
- Q3 FY26 Quarterly Activities Report & Appendix 4C
Follow Audeara into a list and get an email when it puts out news.
Follow Audeara